Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer

Published:2015-03-10 Issue:6 Volume:64 Page:689-696
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Smith Sean G.,Koppolu Bhanu prasanth,Ravindranathan Sruthi,Kurtz Samantha L.,Yang Lirong,Katz Matthew D.,Zaharoff David A.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-015-1672-x.pdf

Reference30 articles.

1. Parkin DM (2008) The global burden of urinary bladder cancer. Scand J Urol Nephrol 42(Suppl 218):12–20

2. Ploeg M, Aben KK, Kiemeney LA (2009) The present and future burden of urinary bladder cancer in the world. World J Urol 27:289–293

3. Kaufman DS, Shipley WU, Feldman AS (2009) Bladder cancer. Lancet 374:239–249

4. Morales A, Eidinger D, Bruce A (1976) Intracavitary Bacillus Calmette–Guerin in the treatment of superficial bladder tumors. J Urol 116:180–183

5. Alexandroff AB, Jackson AM, O’Donnell MA, James K (1999) BCG immunotherapy of bladder cancer: 20 years on. Lancet 353:1689–1694

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of an Injectable Chitosan Hydrogel for the Tunable, Localized Delivery of Immunotherapeutics;ACS Biomaterials Science & Engineering;2024-01-19

2. Revitalizing Cytokine‐Based Cancer Immunotherapy through Advanced Delivery Systems;Macromolecular Bioscience;2023-08-29

3. Focal Cryo-Immunotherapy with Intratumoral IL-12 Prevents Recurrence of Large Murine Tumors;Cancers;2023-04-08

4. Long‐Term Retention Microbubbles with Three‐Layer Structure for Floating Intravesical Instillation Delivery;Small;2023-01-12

5. Layer‐by‐layer interleukin‐12 nanoparticles drive a safe and effective response in ovarian tumors;Bioengineering & Translational Medicine;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3